Friday, Sep 18, 2020 | Last Update : 06:42 PM IST

178th Day Of Lockdown

Maharashtra114584081235431351 Andhra Pradesh6014625080885177 Tamil Nadu5142084589008618 Karnataka4943563830777629 Uttar Pradesh3362942632884771 Delhi2347011981034877 West Bengal2155801870614183 Odisha167161133466722 Telangana1650031335551005 Bihar164224149722855 Assam150349121610528 Kerala12221687341490 Gujarat119088999083271 Rajasthan109088906851293 Haryana103773816901069 Madhya Pradesh97906743981877 Punjab90032658182646 Chhatisgarh7777541111628 Jharkhand6710052807590 Jammu and Kashmir5971138521951 Uttarakhand3713924810460 Goa2678320844327 Puducherry2142816253431 Tripura2069612956222 Himachal Pradesh11190691997 Chandigarh92566062106 Manipur8430653951 Arunachal Pradesh6851496713 Nagaland5306407910 Meghalaya4356234232 Sikkim2119178923 Mizoram15069490
  Science   13 Sep 2020  Covaxin test on animals show sign of hope

Covaxin test on animals show sign of hope

THE ASIAN AGE.
Published : Sep 13, 2020, 3:27 pm IST
Updated : Sep 13, 2020, 3:27 pm IST

The animal trials were conducted on 20 monkeys in India and three different vaccine candidates were tried on them

The results of Bharat Biotech are encouraging but there are queries raised about the effects on the central nervous system which have not been detailed in the animals.
 The results of Bharat Biotech are encouraging but there are queries raised about the effects on the central nervous system which have not been detailed in the animals.

Hyderabad: Animal results of the two-dose, unactivated SARS-Cov 2 vaccine, Covaxin BBV 152, has shown protection and reduction in the replication of SARS-Cov 2 virus in nose, throat and lung tissues.

The animal trials were conducted on 20 monkeys in India and three different vaccine candidates were tried on them. The first dose of vaccine was given on Day 0 and the second dose was given on Day 14.

 

The results showed protective efficacy, increasing SARS-Cov 2-specific immunoglobulins which are antibodies, reducing replication of the virus.

Three groups of monkeys were given the vaccination and one group was not vaccinated. The three vaccinated groups did not develop pneumonia, while the non-vaccination group developed pneumonia.

According to the official note released by Bharat Biotech, there have not been any adverse side-effects noted in the animal trials.  There was a robust immune response as there was protection from SARS Cov-2 virus even when exposed in high amounts.

The results of Bharat Biotech are encouraging but there are queries raised about the effects on the central nervous system which have not been detailed in the animals.

 

Tags: covaxin trial, monkey, animal trial, bharat biotech
Location: India, Telangana, Hyderabad